The Journal of Urology
Volume 184, Issue 2 , Pages 488-493, August 2010

Prostate Specific Antigen Mass Ratio Potential as a Prostate Cancer Screening Tool

Department of Family Medicine, Seoul National University Hospital and Department of Family Medicine, Healthcare System Gangnam Center of Seoul National University Hospital (HTK), Seoul, South Korea

Received 23 November 2009 published online 17 June 2010.

Purpose

Studies suggest lowering the threshold of the prostate specific antigen test in obese men due to the hemodilution effect but prostate specific antigen may be affected by prostate volume and insulin resistance, which also increase with obesity. Thus, we examined the combined effect of these factors on prostate specific antigen.

Materials and Methods

We analyzed 3,461 Korean men 30 to 80 years old with prostate volume data available who underwent routine evaluation. We examined the effect of plasma volume, homeostatic model assessment index, prostate volume and body mass index on prostate specific antigen, and prostate specific antigen mass and mass ratio (total circulating prostate specific antigen protein per prostate volume) by the trend test and/or ANOVA after adjusting for age and/or prostate volume.

Results

Body mass index had positive associations with plasma volume, the homeostatic model assessment index and prostate volume (p for trend <0.01). Prostate specific antigen had a positive association with prostate volume and a negative association with plasma volume (p for trend <0.01) but not with homeostatic model assessment index. The adjusted R2 of prostate volume vs prostate specific antigen was greater than for plasma volume vs prostate specific antigen while for body mass index vs prostate volume it was less than for body mass index vs plasma volume (0.0892, 0.0235, 0.1346 and 0.3360, respectively). Prostate specific antigen mass was not associated with plasma volume or body mass index but it was still associated with prostate volume after adjusting for plasma volume or body mass index (p for trend <0.01). Mean prostate specific antigen mass ratio did not change significantly across body mass index, plasma volume or prostate volume quartiles in men older than 55 years.

Conclusions

It is not logical to lower the prostate specific antigen threshold based on only the hemodilution effect since body mass index related prostate volume enlargement can increase prostate specific antigen in obese men. Another tool is needed and prostate specific antigen mass ratio may be an option.

Key Words: prostate, prostate specific antigen, obesity, insulin resistance, organ size

Abbreviations and Acronyms: BMI, body mass index, HOMA, homeostatic model assessment of IR, IR, insulin resistance, PSA, prostate specific antigen, PV, prostate volume

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supplementary material for this article can be obtained at http://hpc.snuh.org/_Control/skin/2/download.jsp?file_name1=JU-09-2042[1]_attached_table.pdf.

 Study received institutional review board approval.

PII: S0022-5347(10)03265-9

doi:10.1016/j.juro.2010.03.138

The Journal of Urology
Volume 184, Issue 2 , Pages 488-493, August 2010